Tracking tool Meta Pixel was found on 33 of the top 100 US hospitals’ websites; the Environmental Protection Agency (EPA) released new guidance in response to dangerous PFAS levels in drinking water; the US abortion rate rose by 7% between 2017 and 2020.
A tracking tool on many hospital websites has been collecting private health information on patients’ medical conditions, appointments, and prescriptions, and sending it to Facebook, according to a report by The Markup. The tracker, called Meta Pixel, was found on 33 of the top 100 US hospitals’ websites, including John Hopkins Hospital, UCLA Reagan Medical Center, and New York Presbyterian Hospital. When a patient clicked a certain button to schedule an appointment, the tracker sent data connected to an IP address to Facebook. Meta Pixel was also found to be installed in password-protected patient portals of 7 health systems.
As reported by The Washington Post, the Environmental Protection Agency (EPA) warned levels of per- and polyfluoroalkyl substances (PFAS) in drinking water, cosmetics, and food packaging are more dangerous than previously thought. In response, the EPA released new guidance requiring local officials in every state to notify citizens of contamination or install water filters, however the federal government does not currently regulate PFAS. On top of this, the agency is also making $1 billion available through grant funding to help communities on the frontlines of PFAS contamination, and preparing mandatory standards on water utilities to regulate the 2 most common PFAS, PFOA and PFOS.
Reversing a 3-decade decline in US abortion rates, the number of abortions increased between 2017 and 2020, The New York Times reported. As of 2020, 1 in 5 pregnancies, or 20.6%, were terminated via abortion, compared with 18.4% in 2017. These findings were published by the Guttmacher Institute, which found that 930,160 abortions were performed in 2020, an increase of more than 67,000 from 2017. Per 1000 women aged between 15 and 44, the abortion rate rose by 7% during that time period. The report also showed that abortion rates increased more in the West and Midwest United States compared with the South and Northeast regions.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More